Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsAlberto Bottini, Daniele Generali, Maria Pia Brizzi, et al.
Endocrine|September 29, 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?Anna La Salvia, Alessandra Siciliani, Maria Rinzivillo, et al.
The Oncologist|July 15, 2025
Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancerFrancesco Leone, Valeria Fiamma, Francesca Crivelli, et al.
BMC Cancer|September 26, 2023
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trialFrancesca Corti, Maria Pia Brizzi, Vito Amoroso, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine TumorGiuseppe Lamberti, Antongiulio Faggiano, Nicole Brighi, et al.
The Lancet. Oncology|October 28, 2017
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trialPiero Ferolla, Maria Pia Brizzi, Tim Meyer, et al.
Future Oncology (London, England)|March 20, 2014
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community settingGiuseppe Procopio, Lisa Derosa, Angela Gernone, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
Liver Cancer|August 20, 2021
Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular CarcinomaFrancesco Tovoli, Vincenzo Dadduzio, Stefania De Lorenzo, et al.
Cancer Medicine|May 27, 2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumorsRossana Berardi, Mariangela Torniai, Sara Pusceddu, et al.
Pageof 6